ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 357 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 1.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2015 | $338,000 | -26.8% | 2,720 | -66.1% | 0.00% | -66.7% |
Q2 2015 | $462,000 | +2.2% | 8,031 | +13.1% | 0.01% | -40.0% |
Q1 2015 | $452,000 | +33.7% | 7,100 | +29.1% | 0.02% | +87.5% |
Q4 2014 | $338,000 | +125.3% | 5,500 | +42.6% | 0.01% | +60.0% |
Q3 2014 | $150,000 | -27.5% | 3,856 | -35.8% | 0.01% | -50.0% |
Q2 2014 | $207,000 | – | 6,010 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 6,636,526 | $257,696,000 | 10.48% |
WILLIAM HARRIS INVESTORS INC | 309,934 | $12,034,000 | 3.60% |
DOWLING & YAHNKE LLC | 676,298 | $26,261,000 | 3.46% |
GRAYBILL WEALTH MANAGEMENT, LTD. | 90,240 | $3,504,000 | 2.69% |
HWG Holdings LP | 58,395 | $2,267,000 | 1.82% |
Iguana Healthcare Management, LLC | 85,000 | $3,300,000 | 1.76% |
PINNACLE ASSOCIATES LTD | 1,845,727 | $71,670,000 | 1.46% |
Adamant Biomedical Investments AG | 140,000 | $5,436,000 | 1.36% |
Apex Capital Management | 843,791 | $32,764,000 | 0.99% |
PERKINS CAPITAL MANAGEMENT INC | 28,465 | $1,105,000 | 0.93% |